CR20120654A - Procedimiento de preparación de la sal de l-arginina de perindoprilo - Google Patents
Procedimiento de preparación de la sal de l-arginina de perindopriloInfo
- Publication number
- CR20120654A CR20120654A CR20120654A CR20120654A CR20120654A CR 20120654 A CR20120654 A CR 20120654A CR 20120654 A CR20120654 A CR 20120654A CR 20120654 A CR20120654 A CR 20120654A CR 20120654 A CR20120654 A CR 20120654A
- Authority
- CR
- Costa Rica
- Prior art keywords
- perindoprile
- preparation procedure
- arginine salt
- salt preparation
- arginine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
Abstract
PROCEDIMIENTO DE PREPARACIÓN DEL COMPUESTO DE FÓRMULA (I).-
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1200034A FR2985512B1 (fr) | 2012-01-05 | 2012-01-05 | Procede de preparation du sel de l-arginine du perindopril |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20120654A true CR20120654A (es) | 2013-09-03 |
Family
ID=47427278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20120654A CR20120654A (es) | 2012-01-05 | 2012-12-19 | Procedimiento de preparación de la sal de l-arginina de perindoprilo |
Country Status (46)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
| TWI544987B (zh) | 2015-10-27 | 2016-08-11 | 財團法人工業技術研究院 | 輕便型動力工具 |
| WO2019071209A1 (en) | 2017-10-06 | 2019-04-11 | Rad Steve | SYSTEM AND KIT OF INCREASED REALITY |
| US10430658B2 (en) | 2017-10-06 | 2019-10-01 | Steve Rad | Augmented reality system and kit |
| CN110283104B (zh) * | 2018-08-22 | 2022-06-14 | 南京济群医药科技股份有限公司 | 一种精氨酸培哚普利的制备方法 |
| CN112047999B (zh) * | 2020-09-18 | 2022-12-02 | 天津力生制药股份有限公司 | 一种γ晶型的精氨酸培哚普利盐的制备方法 |
| CN114149357A (zh) * | 2021-12-29 | 2022-03-08 | 江苏嘉逸医药有限公司 | 一种γ晶型培哚普利精氨酸盐的制备方法 |
| CN114894940A (zh) * | 2022-06-02 | 2022-08-12 | 江苏嘉逸医药有限公司 | 一种高效液相色谱法测定精氨酸培哚普利中杂质的方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2503155A2 (fr) * | 1980-10-02 | 1982-10-08 | Science Union & Cie | Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
| FR2620709B1 (fr) * | 1987-09-17 | 1990-09-07 | Adir | Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese |
| AR036187A1 (es) * | 2001-07-24 | 2004-08-18 | Adir | Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario |
| FR2838648B1 (fr) * | 2002-04-18 | 2004-05-21 | Servier Lab | Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent |
| EP2472333A1 (en) | 2003-09-18 | 2012-07-04 | Xeikon IP BV | Method of preparation of a liquid electrostatographic toner and liquid electrostatographic toner |
| US7291745B2 (en) * | 2005-03-21 | 2007-11-06 | Glenmark Pharmaceuticals Limited | Process for the preparation of perindopril |
| FR2897866B1 (fr) * | 2006-02-28 | 2008-04-18 | Servier Lab | Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
| FR2897865B1 (fr) * | 2006-02-28 | 2008-04-18 | Servier Lab | Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
| EP1864973A1 (en) * | 2006-06-09 | 2007-12-12 | Sochinaz SA | Process for the preparation of perindopril and salts thereof |
| HUE025982T2 (en) * | 2008-06-24 | 2016-05-30 | Mylan Laboratories Ltd | New polymorphic forms of perindopril (L) -arginine and a process for their preparation |
| AU2009212902A1 (en) * | 2008-09-03 | 2010-03-18 | Apotex Pharmachem Inc. | Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof |
| SI23001A (sl) * | 2009-03-20 | 2010-09-30 | Diagen@d@o@o | Nove soli perindoprila nov postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni |
-
2012
- 2012-01-05 FR FR1200034A patent/FR2985512B1/fr not_active Expired - Fee Related
- 2012-12-18 PH PH12012000392A patent/PH12012000392A1/en unknown
- 2012-12-19 CR CR20120654A patent/CR20120654A/es unknown
- 2012-12-19 JO JOP/2012/0384A patent/JO3196B1/ar active
- 2012-12-19 SG SG2012093589A patent/SG192337A1/en unknown
- 2012-12-20 AU AU2012268816A patent/AU2012268816B2/en active Active
- 2012-12-20 PE PE2012002463A patent/PE20131098A1/es not_active Application Discontinuation
- 2012-12-20 IL IL223753A patent/IL223753A/en active IP Right Grant
- 2012-12-25 TN TNP2012000620A patent/TN2012000620A1/fr unknown
- 2012-12-26 CO CO12232909A patent/CO6700138A1/es unknown
- 2012-12-27 TW TW101150662A patent/TWI449693B/zh active
- 2012-12-27 MY MYPI2012701295A patent/MY160902A/en unknown
- 2012-12-27 NI NI201200195A patent/NI201200195A/es unknown
- 2012-12-27 UY UY0001034553A patent/UY34553A/es unknown
- 2012-12-28 EA EA201201667A patent/EA022573B1/ru unknown
- 2012-12-28 MD MDA20120129A patent/MD4415C1/ro active IP Right Grant
-
2013
- 2013-01-02 AP AP2013006655A patent/AP2013006655A0/xx unknown
- 2013-01-02 MA MA35525A patent/MA35001B1/fr unknown
- 2013-01-02 SA SA113340172A patent/SA113340172B1/ar unknown
- 2013-01-03 AR ARP130100016A patent/AR089632A1/es not_active Application Discontinuation
- 2013-01-03 UA UAA201300118A patent/UA111333C2/uk unknown
- 2013-01-03 CA CA 2801089 patent/CA2801089C/fr active Active
- 2013-01-03 US US13/733,353 patent/US8865915B2/en active Active
- 2013-01-03 CL CL2013000022A patent/CL2013000022A1/es unknown
- 2013-01-04 PT PT131503054T patent/PT2612851T/pt unknown
- 2013-01-04 CN CN201310001282.2A patent/CN103193863B/zh active Active
- 2013-01-04 EC ECSP13012366 patent/ECSP13012366A/es unknown
- 2013-01-04 ES ES13150305.4T patent/ES2595236T3/es active Active
- 2013-01-04 KR KR1020130001012A patent/KR101502946B1/ko active IP Right Grant
- 2013-01-04 EP EP13150305.4A patent/EP2612851B1/fr active Active
- 2013-01-04 HU HUE13150305A patent/HUE030042T2/en unknown
- 2013-01-04 RS RS20160720A patent/RS55096B1/sr unknown
- 2013-01-04 CU CUP2013000003A patent/CU24293B1/es unknown
- 2013-01-04 GE GEAP201312951A patent/GEP20146183B/en unknown
- 2013-01-04 JP JP2013000108A patent/JP5722924B2/ja active Active
- 2013-01-04 WO PCT/FR2013/050017 patent/WO2013102740A1/fr active Application Filing
- 2013-01-04 SI SI201330308A patent/SI2612851T1/sl unknown
- 2013-01-04 LT LTEP13150305.4T patent/LT2612851T/lt unknown
- 2013-01-04 DK DK13150305.4T patent/DK2612851T3/en active
- 2013-01-04 ME MEP-2016-171A patent/ME02493B/me unknown
- 2013-01-04 PL PL13150305.4T patent/PL2612851T3/pl unknown
- 2013-01-04 BR BR102013000256-9A patent/BR102013000256B1/pt active IP Right Grant
- 2013-01-04 GT GT201300002A patent/GT201300002A/es unknown
- 2013-01-07 MX MX2013000009A patent/MX2013000009A/es active IP Right Grant
-
2016
- 2016-09-06 HR HRP20161145TT patent/HRP20161145T1/hr unknown
- 2016-10-05 CY CY20161100993T patent/CY1118079T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY34523A (es) | Derivados de betulina | |
| UY35683A (es) | Polimorfo de inhibidores de tirosina quinasa de bazo (syk) | |
| CR20140463A (es) | Compuestos de heterociclilo como inhibidores de mek | |
| CR20140510A (es) | Nucleósidos de espirooxetano de uracilo | |
| CR20120654A (es) | Procedimiento de preparación de la sal de l-arginina de perindoprilo | |
| CR20150271A (es) | Peptidos como agonistas de oxitocina | |
| CR20140042A (es) | Indazoles | |
| CR20130539A (es) | Triazolopiridinas | |
| CR20150061A (es) | Compuesto de pirazolopirimidinas | |
| UY34472A (es) | Derivados modificados de 4-fenil-piridina | |
| CR20140468A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| UY34365A (es) | Compuestos heterociclicos | |
| UY34503A (es) | ?sal de bromhidrato de pridopidina? | |
| UY34654A (es) | Inhibidores de la beta-secretasa | |
| CR20140535A (es) | Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa | |
| CR20130419A (es) | Derivados heterocíclicos de amina | |
| CR20120637A (es) | Triazolopiridinas sustituidas | |
| BR112014003027A2 (pt) | formulação herbicida melhorada | |
| CR20150084A (es) | 2-oxo-2,3-dihidro-indoles | |
| CR20140322A (es) | Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2 | |
| UY34286A (es) | Diagnóstico de vacuna mejorado | |
| DOP2015000007A (es) | Métodos para preparar triazolopiridinas sutituidas | |
| CR20150087A (es) | Derivados de pirazol-carboxamida | |
| BR112014009760A8 (pt) | análogos de ácido siálico | |
| CR20150028A (es) | Derivados de ariletinilo |